Other genomic alterations of GBM include telomerase reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) amplification, and tumor suppressor phosphatase and tensin homolog on chromosome 10 (PTEN) loss/mutation. This evidence concerns the gene EGFR and glioblastoma.